Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration

Experiments on rats trained passive avoidance task showed that N-phenyl-acetyl-L-prolyl-glycyl ethyl ester, peptide analog of piracetam (GVS-111, Noopept) after oral administration retained antiamnesic activity previously observed after its parenteral administration. Effective doses were 0.5-10 mg/k...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine Vol. 132; no. 4; pp. 959 - 962
Main Authors: Ostrovskaya, R U, Mirsoev, T K, Romanova, G A, Gudasheva, T A, Kravchenko, E V, Trofimov, C C, Voronina, T A, Seredenin, S B
Format: Journal Article
Language:English
Published: United States Springer Nature B.V 01-10-2001
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Experiments on rats trained passive avoidance task showed that N-phenyl-acetyl-L-prolyl-glycyl ethyl ester, peptide analog of piracetam (GVS-111, Noopept) after oral administration retained antiamnesic activity previously observed after its parenteral administration. Effective doses were 0.5-10 mg/kg. Experiments on a specially-developed model of active avoidance (massive one-session learning schedule) showed that GVS-111 stimulated one-session learning after single administration, while after repeated administration it increased the number of successful learners among those animals who failed after initial training. In this respect, GVS-111 principally differs from its main metabolite cycloprolylglycine and standard nootropic piracetam.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-4888
1573-8221
DOI:10.1023/A:1013663126973